Cardiac magnetic resonance imaging


How does cardiac magnetic resonance imaging produce images?

  • Cardiac magnetic resonance (CMR) uses a strong magnet 1.5 to 3.0 Tesla (equivalent to 30,000–60,000 times the strength of the earth’s magnetic field), radiofrequency pulses, and gradient magnetic fields to obtain images of the heart. When placed in the bore of a magnet, positively charged protons, mainly from water, are aligned in the direction of the magnetic field creating a net magnetization. Radiofrequency pulses are used to tilt these protons away from their alignment, shifting them to a higher energy state. These protons then return to their equilibrium state through the process of relaxation and emit a signal. The relaxation consists of two components—T1 and T2 relaxation. Magnetic gradients are applied across the tissue of interest to localize these signals. The signals are then collected using a receiver coil and placed in a data space referred to as k-space, which is then used to create an image. CMR uses differences in relaxation properties between and among different tissues, fluids, and blood, and changes that occur due to pathological processes to create contrast in the image.

What is unique about CMR?

  • Similar to echocardiography, CMR allows the generation of images of the heart without exposure to ionizing radiation. Although the spatial resolution of CMR is comparable to echocardiography (~1 mm), the contrast-to-noise and signal-to-noise ratios are far superior ( Fig. 10.1 ). The latter allows easier delineation of borders between tissues and in particular between blood pool and myocardium. The contrast between blood pool and myocardium is generated using differences in signal properties of the different tissues without the use of contrast agents. CMR is also not limited by “acoustic windows” that may hinder echocardiography, and images can be obtained in any tomographic plane. Finally, CMR can provide information about tissue characteristics using differences in T1 and T2 signals, with the addition of contrast agents.

    Fig. 10.1, Comparison of (A) an echocardiographic and (B) cardiac magnetic resonance imaging cine image of a four-chamber view of the same patient. The superior contrast-to-noise and signal-to-noise ratios are clearly evident in the cardiac magnetic resonance image, with clear delineation of the endocardial and epicardial borders of both ventricles.

What are the limitations of CMR?

  • The major limitation of CMR is availability. Given the cost, the special construction necessary to host a CMR system, and the technical expertise and support necessary, CMR is not widely available at all centers. CMR is limited with respect to portability, unlike echocardiography where imaging can be performed at the patient’s bedside. There are also a set of contraindications ( Table 10.1 ) that limit the use of this technology in selected patient populations. Image acquisition can be challenging in patients with an irregular cardiac rhythm or difficulty breath-holding, though arrhythmia rejection and real-time techniques provide an opportunity to overcome these barriers ( Fig. 10.2 ). Finally since patients have to lie still in a long hollow tube for up to an hour during imaging, claustrophobia may be an important limiting factor.

    Table 10.1
    Appropriate Indications for Cardiac Magnetic Resonance
    • Evaluation of chest pain syndrome in patients with intermediate pretest probability of CAD

    • Evaluation of suspected coronary anomalies

    • Evaluation of LV function after myocardial infarction or in patients with heart failure in patients with technically limited or indeterminant echocardiograms

    • Evaluation of extent of myocardial necrosis and microvascular obstruction (“no reflow”)

    • Evaluation of myocardial viability

    • Evaluation of myocarditis

    • Evaluation of specific cardiomyopathies (e.g., infiltrative cardiomyopathies, HCM)

    • Characterization of native and prosthetic cardiac valve dysfunction in patients with technically limited images from echocardiogram or TEE

    • Evaluation of suspected constrictive pericarditis

    • Evaluation of cardiac and pericardial masses

    • Evaluation of pulmonary veins before pulmonary vein isolation for atrial fibrillation

    • Assessment of congenital heart disease

    • Evaluation for aortic dissection

    CAD, Coronary artery disease; HCM, hypertrophic cardiomyopathy; LV, left ventricular; TEE, transesophageal echocardiogram.

    Fig. 10.2, A, Four-chamber view in a patient with difficulty breath-holding resulting in a blurry image. B, The same patient who was able to breath-hold after the acquisition period was shortened. C, Another patient with a real-time acquisition with the patient breathing freely.

What are the common imaging pulse sequences used in CMR?

  • Pulse sequences are orchestrated actions of turning on and off various coils, gradients, and radiofrequency pulses to produce a CMR image. In simple terms, the pulse sequences are based on either gradient echo or spin echo sequences. The most common sequences used are bright blood gradient echo sequences (where the blood pool is bright), dark blood spin echo sequences (where the blood pool is dark), steady-state free precession sequences (also a type of gradient echo sequence, and most commonly used for function or cine images), and inversion recovery sequences (e.g., late gadolinium enhancement [LGE] imaging used to assess myocardial scar).

What are the appropriate uses of CMR?

  • Although echocardiography is usually the first-line imaging modality for questions of left ventricular (LV) function and assessment of valvular disease, cardiac MRI still has many important indications. The following questions and answers pertain to the appropriate use of cardiac MRI in the clinical setting as recommended in the multisociety multimodality appropriateness criteria from 2019. Appropriate uses of CMR are summarized in Table 10.2 .

    Table 10.2
    Common Contraindications to Cardiac Magnetic Resonance
    • Ocular foreign body (e.g., metal in eye)

    • Central nervous system aneurysm clips

    • Implanted neural stimulator

    • Cochlear implant

    • Implanted cardiac pacemaker or defibrillator (see text for caveats)

    • Other implanted medical devices (drug infusion ports, insulin pump)

    • Swan-Ganz catheters

    • Metal shrapnel or bullet

    • Pregnancy

What is late gadolinium enhancement CMR imaging?

  • One of the unique aspects of CMR is the ability to identify myocardial scar/fibrosis. This is most commonly performed using LGE imaging (also known as delayed enhancement imaging). Gadolinium-based contrast agents (GBCAs) are administered intravenously, and then after waiting approximately 10 minutes and allowing time for the contrast to distribute into areas of scar/fibrosis, an inversion recovery gradient echo sequence is performed. This sequence nulls normal myocardium (makes it black), and anything that is bright within the myocardium is most likely myocardial scar/fibrosis ( Fig. 10.3 ).

    Fig. 10.3, Late gadolinium enhancement (LGE) patterns. A, Normal short-axis late gadolinium enhancement image. B, Transmural scar in the circumflex territory. C, Cardiomyopathy secondary to sarcoidosis. D, Hypertrophic obstructive cardiomyopathy with basal anteriorseptal mid-myocardial LGE. E, Myocarditis with both midmyocardial and epicardial LGE. F, Cardiac amyloidosis with diffuse enhancement of the entire left ventricle. The arrowheads point to the areas of myocardial LGE.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here